ETFs Holding ARGS »    ARGS Historical Stock Prices »
ARGS News Video: Mon, May 9, 2016, 11:20 AM — Monday Sector Leaders: Drugs, Biotechnology Stocks

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer based on Co.'s proprietary precision immunotherapy technology platform called Arcelis. Co.'s proprietary Arcelis precision immunotherapy technology platform utilizes biological components from a patient's own cancer cells or virus to generate individualized immunotherapies. Co.'s primary product candidate is rocapuldencel-T, which is for the treatment of metastatic renal cell carcinoma and other cancers. Co. is also developing AGS-004, for the treatment of Human Immunodeficiency Virus. Self directed investors in Argos Therapeutics Inc will be interested in keeping up with all Argos Therapeutics Inc news they can find, both ARGS news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ARGS. At RediNews, we simplify this task by presenting both ARGS news releases originating from Argos Therapeutics Inc itself, and ARGS news from a variety of media outlets. Visitors can browse this news online and through our ARGS RSS news feed.


ARGS News — Articles, Videos, & Press Releases

ARGS is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

AAC News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ARGS News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.